12:00 AM
Jul 22, 2013
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Almirall, GW Pharma sales and marketing update

The partners said Almirall launched Sativex in Italy to treat moderate to severe spasticity in multiple sclerosis patients with inadequate response to other anti-spasticity medications. The partners said the sublingual cannabis extract spray containing tetrahydrocannabinol (THC) and cannabidiol (CBD) has...

Read the full 190 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >